Extracorporeal Magnetotransduction Therapy (EMTT): A state-of-the-art treatment option for musculoskeletal complaints

19 Hits
Extracorporeal Magnetotransduction Therapy (EMTT): A state-of-the-art treatment option for musculoskeletal complaints

High-energy magnetic pulses for the treatment of pain, injuries and degeneration

Musculoskeletal disorders are the most common cause of pain worldwide. Extracorporeal Magnetotransduction Therapy (EMTT) offers doctors and patients a state-of-the-art treatment option based on the latest scientific findings. Discover what makes EMTT unique, including its mode of action and patient-centred approach.

What is Extracorporeal Magnetotransduction Therapy?

EMTT is a non-invasive therapeutic procedure developed specifically for the treatment of (chronic) musculoskeletal disorders. This umbrella term covers a wide range of conditions and symptoms affecting the musculoskeletal system, i.e. muscles, bones, joints, tendons and ligaments. Since its introduction, EMTT has been adopted as a well-tolerated treatment approach and is increasingly gaining significance. Clinical studies have been conducted on EMTT that investigate its use in various indications.1,2,3,4,5

EMTT is used in the field of musculoskeletal complaints, for example in cases of:

  • Degenerative changes: e.g. joint complaints associated with signs of wear and tear
  • Pain-related complaints: e.g. back pain or muscular tension
  • Over-strain and sports-related complaints: e.g. tendinopathy or strain-related complaints

The principle behind EMTT: High-energy magnetic pulses

EMTT is based on the targeted application of high-frequency magnetic fields (100–300 kHz). In the course of therapy, painful areas of the body are treated with high-energy magnetic pulses, the field strength of which lies within the therapeutically effective range – 10 mT (millitesla) and upwards. The energy generated is transferred via a handpiece. There is no temperature increase in the tissue, due to the short duration of the individual pulses.

EMTT differs from other general forms of magnetic field therapy or PEMF (pulsed electromagnetic fields) in its significantly higher oscillation frequency and magnetic field strength, resulting in a strong »effective transduction output«. It can be assumed that the faster the magnetic field pulses or the higher the effective transduction output, the more pronounced the bioelectrical activity in the body will be. Due to its properties, EMTT enables a deep tissue penetration of up to 18 cm, allowing treatment of deep structures and extending the range of clinical applications.

Treatment procedure: What makes EMTT so comfortable for patients?

Treatment with a state-of-the-art EMTT system is easy to administer and comfortable for patients, as it doesn’t require direct skin contact or removal of clothing. The handpiece is positioned directly over the relevant pain region (e.g. lower back, knee, shoulder), and the high-energy magnetic pulses are transmitted to the body.

The EMTT treatment is performed with a frequency of up to 10 pulses per second. Depending on the indication and frequency, a single session lasts between 5 and 20 minutes. Depending on the severity of the condition and the patient’s response to the therapy, up to 8 sessions are carried out over a period of several weeks.

Classification and potential of EMTT

Extracorporeal Magnetotransduction Therapy offers a non-invasive, well-tolerated treatment option for patients with (chronic) musculoskeletal complaints. Its physical properties distinguish it from conventional magnetic field therapies and extend the therapeutic range.

EMTT at a glance:

  • Scientifically proven, non-invasive outpatient therapy
  • Wide range of therapeutic applications
  • Enhanced patient comfort with no need to remove clothing
  • Short treatment time
  • Easily integrated into everyday practice

 

1. Krath A, Klüter T, Stukenberg M, et al. Electromagnetic transduction therapy in non-specific low back pain: A prospective randomised controlled trial. J Orthop. 2017;14(3):410-415. Published 2017 Jun 29. doi:10.1016/j.jor.2017.06.016
2. Klüter T, Krath A, Stukenberg M, et al. Electromagnetic transduction therapy and shockwave therapy in 86 patients with rotator cuff tendinopathy: A prospective randomized controlled trial. Electromagn Biol Med. 2018;37(4):175-183. doi:10.1080/15368378.2018.1499030
3. Klüter T, Ringeisen M, Krath A, Al Muderis M, Mittermayr R. Electromagnetic Transduction Therapy in Patients with Chronic Aseptic Osteitis Pubis. J. Orthop. Ther. JORT. 2018;10:2575–8241. doi: 10.29011/2575-8241.001113.
4. Gerdesmeyer L, Saxena A, Klueter T, Harrasser N, Fullem B, Krath A. Electromagnetic Transduction Therapy for Achilles Tendinopathy: A Preliminary Report on a New Technology. J Foot Ankle Surg. 2017;56(5):964-967. doi:10.1053/j.jfas.2017.06.014
5. Gerdesmeyer L, Knobloch K, Gollwitzer H, Ringeisen M. Prospective double-blinded placebo-controlled trial of high energetic magneto transduction therapy in shoulder joint enthesiopathies. Sports Orthopaedics and Traumatology. 2023 Jun;39(2):212. doi: https://doi.org/10.1016/j.orthtr.2023.03.045.

1